These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32299366)

  • 1. Circulating metabolite profiles to predict response to cardiac resynchronization therapy.
    Gong X; Sun Z; Huang Z; Zhou Q; Yu Z; Chen X; Shao W; Zheng Y; Liang Y; Qin S; Su Y; Ge J
    BMC Cardiovasc Disord; 2020 Apr; 20(1):178. PubMed ID: 32299366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure.
    Nemutlu E; Zhang S; Xu YZ; Terzic A; Zhong L; Dzeja PD; Cha YM
    J Card Fail; 2015 Jun; 21(6):460-9. PubMed ID: 25911126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive plasma metabolites profiling reveals phosphatidylcholine species as potential predictors for cardiac resynchronization therapy response.
    Yang S; Hu Y; Zhao J; Jing R; Wang J; Gu M; Niu H; Chen L; Hua W
    ESC Heart Fail; 2021 Feb; 8(1):280-290. PubMed ID: 33211407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score.
    Bakos Z; Chatterjee NC; Reitan C; Singh JP; Borgquist R
    BMC Cardiovasc Disord; 2018 Apr; 18(1):70. PubMed ID: 29699498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Piccolo R; Galasso G; Reiter RJ
    Int J Cardiol; 2016 Oct; 221():359-63. PubMed ID: 27404706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of notched duration to predict response to cardiac resynchronization therapy.
    Balci MM; Balci KG; Sen F; Maden O; Unal S; Selcuk MT; Selcuk H
    Scand Cardiovasc J; 2015 Aug; 49(4):200-6. PubMed ID: 25920477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are changes in the extent of left ventricular dyssynchrony as assessed by speckle tracking associated with response to cardiac resynchronization therapy?
    Ghani A; Delnoy PP; Ottervanger JP; Ramdat Misier AR; Smit JJ; Adiyaman A; Elvan A
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):553-61. PubMed ID: 26585749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of mechanical dyssynchrony in cardiac resynchronization therapy.
    Risum N
    Dan Med J; 2014 Dec; 61(12):B4981. PubMed ID: 25441737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy when no lateral pacing option exists: vectorcardiographic guided non-lateral left ventricular lead placement predicts acute hemodynamic response.
    Ross S; Odland HH; Aranda A; Edvardsen T; Gammelsrud LO; Haland TF; Cornelussen R; Hopp E; Kongsgaard E
    Europace; 2018 Aug; 20(8):1294-1302. PubMed ID: 29036446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure.
    Padeletti L; Modesti PA; Cartei S; Checchi L; Ricciardi G; Pieragnolia P; Sacchi S; Padeletti M; Alterini B; Pantaleo P; Hu X; Tenori L; Luchinat C
    J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):295-300. PubMed ID: 24699011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a biomarker panel to predict cardiac resynchronization therapy response: Results from the SMART-AV trial.
    Spinale FG; Meyer TE; Stolen CM; Van Eyk JE; Gold MR; Mittal S; DeSantis SM; Wold N; Beshai JF; Stein KM; Ellenbogen KA;
    Heart Rhythm; 2019 May; 16(5):743-753. PubMed ID: 30476543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.
    Vijayaraman P; Herweg B; Ellenbogen KA; Gajek J
    Circ Arrhythm Electrophysiol; 2019 Feb; 12(2):e006934. PubMed ID: 30681348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular Electrical Delay Measured From Body Surface ECGs Is Associated With Cardiac Resynchronization Therapy Response in Left Bundle Branch Block Patients From the MADIT-CRT Trial (Multicenter Automatic Defibrillator Implantation-Cardiac Resynchronization Therapy).
    Plesinger F; Jurak P; Halamek J; Nejedly P; Leinveber P; Viscor I; Vondra V; McNitt S; Polonsky B; Moss AJ; Zareba W; Couderc JP
    Circ Arrhythm Electrophysiol; 2018 May; 11(5):e005719. PubMed ID: 29700054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial viability as shown by left ventricular lead pacing threshold and improved dyssynchrony by QRS narrowing predicts the response to cardiac resynchronization therapy.
    Takenaka M; Inden Y; Yanagisawa S; Fujii A; Ando M; Funabiki J; Murase Y; Otake N; Sakamoto Y; Shibata R; Murohara T
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):311-319. PubMed ID: 30516312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.
    Bleeker GB; Mollema SA; Holman ER; Van de Veire N; Ypenburg C; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    Circulation; 2007 Sep; 116(13):1440-8. PubMed ID: 17785624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronization therapy improves left atrial reservoir function through resynchronization of the left atrium in patients with heart failure with reduced ejection fraction.
    Dokuni K; Matsumoto K; Tatsumi K; Suto M; Tanaka H; Fukuzawa K; Hirata KI
    Int J Cardiovasc Imaging; 2020 Jul; 36(7):1203-1212. PubMed ID: 32185626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined electrical and global markers of dyssynchrony predict clinical response to cardiac resynchronization therapy.
    Bajraktari G; Rönn F; Ibrahimi P; Jashari F; Lindmark K; Jensen SM; Henein MY
    Scand Cardiovasc J; 2014 Oct; 48(5):304-10. PubMed ID: 25117854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.